Next report date
Report period
H1 2024
EPS estimate
−1.48EUR
Revenue estimate
2.30 MEUR
−3.44EUR
−147.74 MEUR
45.89 M
About ABIVAX
Sector
CEO
Marc M. P. de Garidel
Headquarters
Paris
Website
Employees (FY)
61
Founded
2013
ISIN
FR0012333284
FIGI
BBG00JHW6XS0
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0RA9 is 14.74 EUR — it has decreased by 2.38% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange ABIVAX EUR0.01 stocks are traded under the ticker 0RA9.
ABIVAX EUR0.01 is going to release the next earnings report on Sep 9, 2024. Keep track of upcoming events with our Earnings Calendar.
0RA9 stock is 2.45% volatile and has beta coefficient of 1.27. Check out the list of the most volatile stocks — is ABIVAX EUR0.01 there?
Yes, you can track ABIVAX EUR0.01 financials in yearly and quarterly reports right on TradingView.
0RA9 stock has risen by 4.83% compared to the previous week, the month change is a 10.49% rise, over the last year ABIVAX EUR0.01 has showed a 0.96% increase.
0RA9 net income for the last quarter is −95.79 M EUR, while the quarter before that showed −51.95 M EUR of net income which accounts for −84.37% change. Track more ABIVAX EUR0.01 financial stats to get the full picture.
Today ABIVAX EUR0.01 has the market capitalization of 927.40 M, it has increased by 2.86% over the last week.
No, 0RA9 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0RA9 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABIVAX EUR0.01 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 61.00 employees. See our rating of the largest employees — is ABIVAX EUR0.01 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABIVAX EUR0.01 technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABIVAX EUR0.01 stock shows the buy signal. See more of ABIVAX EUR0.01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ABIVAX EUR0.01 future price: according to them, 0RA9 price has a max estimate of 33.44 EUR and a min estimate of 14.95 EUR. Read a more detailed ABIVAX EUR0.01 forecast: see what analysts think of ABIVAX EUR0.01 and suggest that you do with its stocks.